The association between STK11/LKB1 and/or KEAP1 mutations and response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer (NSCLC). This is an ASCO Meeting Abstract from the ...
—Adopting evidence-based, unified scoring criteria specifically validated for colorectal cancer could help ensure that the right patients receive the right targeted treatment at the right time. Human ...
Expert Rev Mol Diagn. 2008;8(4):417-434. The College of American Pathologists (CAP) and ASCO recently organized an expert panel, which conducted a systematic review of the literature and developed ...
High Expression of FGD3, a Putative Regulator of Cell Morphology and Motility, Is Prognostic of Favorable Outcome in Multiple Cancers We optimized and validated immunohistochemistry assays in breast ...
BOSTON--(BUSINESS WIRE)--Ibex Medical Analytics (Ibex), the leader in artificial intelligence (AI)-powered cancer diagnostics, today announced the publication of a clinical study evaluating Ibex ...
The HER2-low and HER2-ultralow breast cancer subtype designations have led to a changed landscape in HER2-directed therapies, as well as a desire for more sensitive assays that may better quantify ...
AI assistance reduced the misclassification of HER2-low and HER2-ultralow breast cancers as HER2-null by 24%. An online training platform integrated with artificial intelligence (AI) can help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback